129 related articles for article (PubMed ID: 6804113)
1. Propranolol in angina pectoris. Comparison of long-acting and standard-formulation propranolol.
Parker JO; Porter A; Parker JD
Circulation; 1982 Jun; 65(7):1351-5. PubMed ID: 6804113
[TBL] [Abstract][Full Text] [Related]
2. Slow release oxprenolol in angina pectoris: study comparing oxprenolol, once daily, with propranolol, four times daily.
Olowoyeye JO; Thadani U; Parker JO
Am J Cardiol; 1981 May; 47(5):1123-7. PubMed ID: 7223659
[TBL] [Abstract][Full Text] [Related]
3. Comparative effects of long-acting and conventional propranolol on stress-induced angina pectoris and on frequency of ventricular premature beats.
Hansteen V; Endresen K; Hellemann H; Eriksen II; Brorssen O; Ekeli T; Day M; Baber NS
Br J Clin Pharmacol; 1984 May; 17(5):579-84. PubMed ID: 6203546
[TBL] [Abstract][Full Text] [Related]
4. Propranolol in angina pectoris: duration of improved exercise tolerance and circulatory effects after acute oral administration.
Thadani U; Parker JO
Am J Cardiol; 1979 Jul; 44(1):118-25. PubMed ID: 377932
[TBL] [Abstract][Full Text] [Related]
5. Comparison of oral propranolol and verapamil for combined systemic hypertension and angina pectoris. A placebo-controlled double-blind randomized crossover trial.
Frishman WH; Klein NA; Klein P; Strom JA; Tawil R; Strair R; Wong B; Roth S; LeJemtel TH; Pollack S; Sonnenblick EH
Am J Cardiol; 1982 Nov; 50(5):1164-72. PubMed ID: 6127946
[TBL] [Abstract][Full Text] [Related]
6. Comparison of slow-release pindolol, standard pindolol, and propranolol in angina pectoris.
Parker JO
Am J Cardiol; 1983 Apr; 51(7):1062-6. PubMed ID: 6404149
[TBL] [Abstract][Full Text] [Related]
7. Comparison of celiprolol and propranolol in stable angina pectoris. Celiprolol International Angina Study Group.
Frishman WH; Heiman M; Soberman J; Greenberg S; Eff J
Am J Cardiol; 1991 Apr; 67(8):665-70. PubMed ID: 1672481
[TBL] [Abstract][Full Text] [Related]
8. Comparison of atenolol with propranolol in the treatment of angina pectoris with special reference to once daily administration of atenolol.
Jackson G; Harry JD; Robinson C; Kitson D; Jewitt DE
Br Heart J; 1978 Sep; 40(9):998-1004. PubMed ID: 101223
[TBL] [Abstract][Full Text] [Related]
9. Double-blind comparison of once daily betaxolol versus propranolol four times daily in stable angina pectoris. Betaxolol Investigators Group.
Narahara KA
Am J Cardiol; 1990 Mar; 65(9):577-82. PubMed ID: 2178381
[TBL] [Abstract][Full Text] [Related]
10. Effect of a twelve-hour hiatus in propranolol therapy on exercise tolerance in patients with angina pectoris.
Bassan MM; Weiler-Ravell D
Am Heart J; 1983 Feb; 105(2):234-8. PubMed ID: 6823805
[TBL] [Abstract][Full Text] [Related]
11. Comparative antianginal effects of bepridil and propranolol in angina pectoris.
Parker JO; Farrell B
Am J Cardiol; 1986 Sep; 58(6):449-52. PubMed ID: 3529909
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the new beta-adrenoceptor antagonist, nadolol, and propranolol in the treatment of angina pectoris.
Furberg B; Dahlqvist A; Raak A; Wrege U
Curr Med Res Opin; 1978; 5(5):388-93. PubMed ID: 26520
[TBL] [Abstract][Full Text] [Related]
13. Comparison of nifedipine alone with propranolol alone for stable angina pectoris including hemodynamics at rest and during exercise.
Higginbotham MB; Morris KG; Coleman RE; Cobb FR
Am J Cardiol; 1986 May; 57(13):1022-8. PubMed ID: 3085464
[TBL] [Abstract][Full Text] [Related]
14. [Atenolol in the treatment of angina pectoris].
Bachmann M; Raeber E; Burckhardt D; Schwytzer F; Münch U; Kappenberger L; Nager F
Schweiz Med Wochenschr; 1979 Dec; 109(47):1857-60. PubMed ID: 531563
[TBL] [Abstract][Full Text] [Related]
15. Dose response effectiveness of propranolol for the treatment of angina pectoris.
Alderman EL; Davies RO; Crowley JJ; Lopes MG; Brooker JZ; Friedman JP; Graham AF; Matlof HJ; Harrison DC
Circulation; 1975 Jun; 51(6):964-75. PubMed ID: 805675
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of nicorandil versus propranolol in mild stable angina pectoris of effort: a long-term, double-blind, randomized study.
Meeter K; Kelder JC; Tijssen JG; Bucx JJ; Henneman JA; Kerker JP; Hugenholtz PG
J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S59-66. PubMed ID: 1282178
[TBL] [Abstract][Full Text] [Related]
17. Effect on exercise tolerance and pharmacokinetics of conventional and sustained release preparations of propranolol in patients with angina pectoris--a double-blind cross-over study.
Kambara H; Kinoshita M; Hirota Y; Kadota K; Sawamura M; Saito T; Kawai C
Jpn Circ J; 1984 Oct; 48(10):1066-73. PubMed ID: 6387210
[TBL] [Abstract][Full Text] [Related]
18. Comparison of propranolol, diltiazem, and nifedipine in the treatment of ambulatory ischemia in patients with stable angina. Differential effects on ambulatory ischemia, exercise performance, and anginal symptoms. The ASIS Study Group.
Stone PH; Gibson RS; Glasser SP; DeWood MA; Parker JD; Kawanishi DT; Crawford MH; Messineo FC; Shook TL; Raby K
Circulation; 1990 Dec; 82(6):1962-72. PubMed ID: 2122926
[TBL] [Abstract][Full Text] [Related]
19. Metoprolol in angina pectoris complicated by essential hypertension. A clinical comparison of the antianginal efficacy of metoprolol slow-release tablets (Durules) given once daily and propranolol tablets given twice daily.
BLoem TJ; Lindner PC
Ann Clin Res; 1981; 13 Suppl 30():61-7. PubMed ID: 6794420
[TBL] [Abstract][Full Text] [Related]
20. Propranolol and LB 46 (prinodolol) in angina pectoris. A comparative long-term ergometric study.
Arstila M; Kallio V; Wendelin H
Ann Clin Res; 1973 Apr; 5(2):91-100. PubMed ID: 4201295
[No Abstract] [Full Text] [Related]
[Next] [New Search]
